rolipram has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dastgheib, M | 2 |
| Shetab-Boushehri, SV | 1 |
| Baeeri, M | 1 |
| Gholami, M | 1 |
| Karimi, MY | 1 |
| Hosseini, A | 2 |
| Falak, R | 1 |
| Moghaddam, MV | 1 |
| Hassanzadeh, G | 1 |
| Safa, M | 1 |
2 other studies available for rolipram and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons.
Topics: Adenosine Monophosphate; Animals; Biomarkers; Cyclooxygenase 2; Diabetic Neuropathies; Ganglia, Spin | 2022 |
Rolipram and pentoxifylline combination ameliorates the morphological abnormalities of dorsal root ganglion neurons in experimental diabetic neuropathy by reducing mitochondrial dysfunction and apoptosis.
Topics: Adenosine Triphosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cytochromes c; Di | 2023 |